Penulis: Julian A. Tanner

Andrew D. Miller, Ph D, is currently Professor of Organic Chemistry and Chemical Biology at Mendel University in Brno, Czech Republic, and founder/CSO of KP Therapeutics (Europe) s.r.o., a nanomedicine and precision therapeutics company, also based in the Czech Republic. Julian A. Tanner, Ph D, is a Professor of the School of Biomedical Sciences, Assistant Dean of the LKS Faculty of Medicine, and Director of the Common Core at the University of Hong Kong.